Efficacy of (177)Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study

Peptide receptor radionuclide therapy (PRRT) has been recently established as a treatment option for progressive gastro-entero-pancreatic neuroendocrine tumors (NETs) including four 200 mCi induction cycles. The purpose of this phase 2 trial is to expand use of PRRT to different types of NETs with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sistani, Golmehr, Sutherland, Duncan E. K., Mujoomdar, Amol, Wiseman, Daniele P., Khatami, Alireza, Tsvetkova, Elena, Reid, Robert H., Laidley, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816182/
https://www.ncbi.nlm.nih.gov/pubmed/33622997
http://dx.doi.org/10.3390/curroncol28010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816182/
https://www.ncbi.nlm.nih.gov/pubmed/33622997
http://dx.doi.org/10.3390/curroncol28010015

Ejemplares similares